Departmental Publications

2013 Publications


  1. Burton EC, Mossa-Basha M. To image or to autopsy? Ann Intern Med 2012 Jan17;156(2)158-9.
  2. Gibbs WN, Opatowsky MJ, Burton EC. AIRP best cases in radiologic-pathologic correlation: cerebral fat embolism syndrome in sickle cell β-thalassemia. Radiographics. 2012 Sep-Oct;32(5):1301-6.


  1. Kent OA, Fox-Talbot K, Halushka MK. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013 May 16;32(20):2576-85.
  2. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol 2013 May-Jun;22(3):189-94.
  3. Murphy E, Steenbergen C. Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore? Circ Res 2013 Sep 13;113(7):852-5.
  4. Park JK, Rosen A, Saffitz JE, Asimaki A, Litovsky SH, Mackey-Bojack SM, Halushka MK. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis. Rheumatology (Oxford) 2013 Aug;52(8):1529-33.
  5. Selvin E, Coresh J, Halushka MK.. Response to comments on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116ÔÇô21. Diabetes 2013 Oct;62(10):e27.
  6. Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res 2013 Aug;113(4):464-77.


  1. Breaud AR, Henemyre-Harris CL, Schools S, Emezienna N, Clarke W. Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2013 Mar 15;418:102-6.
  2. Clarke W, Rhea JM, Molinaro R. Challenges in implementing clinical liquid chromatography-tandem mass spectrometry methods - seeing the light at the end of the tunnel. J Mass Spectrom 2013 Jul;48(7):755-67.
  3. Fuzery AK, Breaud AR, Emezienna N, Schools S, Clarke W. A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2013 June;421:79-84.
  4. Fuzery AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 2013 Oct;10(1):13.
  5. Li D, Chiu H, Chen J, Zhang H, Chan DW. Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format. Clin Chem 2013 Jan;59(1):315-24.
  6. Li D, Chiu H, Zhang H, Chan DW. Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA). Clin Proteomics 2013 Sep 9;10(1):12.
  7. Li QK, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomics using so-called 'fluid-biopsy' specimens in the discovery of lung cancer biomarkers. Promise and challenge. Proteomics Clin Appl 2013 Jan;7(1-2):55-69.
  8. Li QK, Shah P, Li Y, Aiyetan PO, Chen J, Yung R, Molena D, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. J Proteome Res 2013 Aug;12(8):3689ÔÇô96.
  9. Marzinke MA, Breaud AR, Clarke W. The development and clinical validation of a turbulent-flow liquid chromatography-tandem mass spectrometric method for the rapid quantitation of docetaxel in serum. Clin Chim Acta 2013 Feb 18;417:12-8.
  10. Marzinke MA, Choi CH, Chen L, Shih IeM, Chan DW, Zhang H. Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery. Mol Cell Proteomics 2013 Feb;12(2):356-68.
  11. Olson MT, Breaud A, Harlan R, Emezienna N, Schools S, Yergey AL, Clarke W. Alternative calibration strategies for the clinical laboratory: application to Nortriptyline therapeutic drug monitoring. Clin Chem 2013 Jun;59(6):920-7.
  12. Seserko LA, Emory JF, Hendrix CW, Marzinke MA. The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma. Bioanalysis 2013 Nov;5(22):2771-83.
  13. Shah P, Yang S, Sun S, Aiyetan P, Yarema KJ, Zhang H. Mass spectrometric analysis of sialylated glycans with use of solid-phase labeling of sialic acids. Anal Chem 2013 Apr 2;85(7):3606-13.
  14. Sun S, Zhang B, Aiyetan P, Zhou JY, Shah P, Yang W, Levine DA, Zhang Z, Chan DW, Zhang H. Analysis of N-glycoproteins using genomic N-glycosite prediction. J Proteome Res 2013 Dec 6;12(12):5609-15.


  1. Ali SZ, Fish SA, Lanman R, Randolph GW, Sosa JA. Use of the afirma gene expression classifier for preoperative identification of benign thyroid nodules with indeterminate fine needle aspiration cytopathology. PLoS Curr 2013 Feb 11;5.
  2. Bishop JA, Yonescu R, Batista DA, Westra WH, Ali SZ. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 2013 May;121(5):228-33.
  3. Bishop JA, Zhang W, Ioffe OB, Ali SZ. Aspiration cytopathology of peripancreatic space: a clinicoradiologic and cytopathologic analyses of 42 cases. Korean J Pathol 2013 Jun;47:258-64.
  4. Boonyaarunnate T, Olson MT, Ali SZ. Impact of flow cytometry in thyroid cytopathology. Acta Cytologica 2013 Nov-Dec;57(6):562-6.
  5. Boonyaarunnate T, Olson MT, Ali SZ. 'Suspicious for a Follicular Neoplasm' before and after the Bethesda System for reporting thyroid cytopathology: impact of standardized terminology. Acta Cytol 2013 Sept;57(5):455-63.
  6. Boonyaarunnate T, Olson MT, Bishop JA, Yang GC, Ali SZ. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration. Acta Cytol 2013 Mar-Apr;57(2):127-33.
  7. Cimino-Mathews A, Illei PB. Cytologic and histologic findings of iron pill-induced injury of the lower respiratory tract. Diagn Cytopathol 2013 Oct;41(10):901-3.
  8. Collins JA, Novak A, Ali SZ, Olson MT. Cytotechnologists and on-site evaluation of adequacy. Korean J Pathol 2013 Oct;47(5):405ÔÇô10.
  9. Guan H, Vandenbussche CJ, Erozan YS, Rosenthal DL, Tatsas AD, Olson MT, Zheng R, Auger M, Ali SZ. Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy. Acta Cytol 2013 Sept-Oct;57(5):534-42.
  10. Illei PB, Maleki Z, Lin MT. EGFR/KRAS/BRAF mutation analysis of metastatic lung adenocarcinoma in spinal fluid. J Am Soc Cytopathol 2013 Oct;2(1 Sup):S17-8.
  11. Holmes BJ, Castelino-Prabhu S, Rosenthal DL, Ali SZ. Xanthogranuloma of bone: a challenging imitator of malignancy. Acta Cytol 2013 Mar-Apr;57(2):198-202.
  12. LeBlanc RE, Maleki Z. Herpes simplex viral cytopathic effect in urine cytology. Diagn Cytopathol 2013 Jan;41(1):61-2.
  13. Li QK, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomics using so-called 'fluid-biopsy' specimens in the discovery of lung cancer biomarkers. Promise and challenge. Proteomics Clin Appl 2013 Jan;7(1-2):55-69.
  14. Li QK, Nugent SL, Straseski J, Cooper D, Riedel S, Askin FB, Sokoll LJ. Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma. Cancer Cytopathol 2013 Aug;121(8):440-8.
  15. Li Y, Wang X, Ao M, Gabrielson E, Askin F, Zhang H, Li QK. Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry. Clin Proteomics 2013 Nov 1;10(1):15.
  16. Maleki Z, Erozan Y, Geddes S, Li QK. Endorectal ultrasound-guided fine needle aspiration: A useful diagnostic tool for peri-rectal and intraluminal lesions. Acta Cytol 2013 Jan;57:9-18.
  17. Munfus-McCray D, Cui M, Zhang Z, Gabrielson E, Askin F, Li QK. Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect. Hum Pathol 2013 Jul;44(7):1286-92.
  18. Olson MT, Boonyaarunnate T, Aragon Han P, Umbricht CB, Ali SZ, Zeiger MA. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens. J Clin Endocrinol Metab 2013 Apr;98(4):1450-7.
  19. Olson MT, Novak A, Kirby J, Boonyaarunnate T, Ali SZ. Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue. Acta Cytologica 2013 Nov-Dec;57:550-6.
  20. Olson MT, Nuransoy A, Ali SZ. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis. Acta Cytol 2013 Mar-Apr;57(2):177-83.
  21. Olson MT, Siddiqui MT, Ali SZ. The differential diagnosis of squamous cells in pancreatic aspirates: from contamination to adenosquamous carcinoma. Acta Cytol 2013 Mar-Apr;57(2):139-46.
  22. Olson MT, Wakely PE Jr, Ali SZ. Metastases to the pancreas diagnosed by fine-needle aspiration. Acta Cytol 2013 Sept-Oct;57(5):473-80.
  23. Owens C, VandenBussche C, Burroughs F, Rosenthal DL. A review of reporting systems and terminology for urine cytology. Cancer Cytopathol 2013 Jan;121(1):9-14.
  24. Rodriquez E, Netto G, Li QK. Intrapancreatic accessory spleen: a potential cause of misdiagnosis at EUS FNA. A case report and review of literature. Diagn Cytopathol 2013;41:466-9.
  25. Rosenthal DL, Vandenbussche CJ, Burroughs FH, Sathiyamoorthy S, Guan H, Owens C. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol. 2013 Jan;121(1):15-20.
  26. Sathiyamoorthy S, Ali SZ. Malignant melanoma in neo-bladder urinary cytology: a brief report. Diagn Cytopathol 2013 Nov;41(11):997-9.
  27. Sathiyamoorthy S, Ali SZ. Urinary cytology of prostatic duct adenocarcinoma - a clinicopathologic analysis. Acta Cytol 2013 Mar - Apr;57(2):184-8.
  28. Subhawong AP, Subhawong TK, Vandenbussche CJ, Siddiqui MT, Ali SZ. Lymphoproliferative disorders of the kidney on fine-needle aspiration: cytomorphology and radiographic correlates in 33 cases. Acta Cytol 2013 Feb;57(1):19-25.
  29. Toll AD, Ali SZ. Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma. Acta Cytol. 2013 Sept;57(5):495-500.
  30. Toll AD, Wakely PE Jr, Ali SZ. Acral myxoinflammatory fibroblastic sarcoma: cytopathologic findings on fine-needle aspiration. Acta Cytol 2013 Mar-Apr;57(2):134-8.
  31. Vandenbussche CJ, Gocke CD, Li QK. Fine-needle aspiration of metastatic papillary thyroid carcinoma found in the liver. Diagn Cytopathol 2013 May;41(5):418-24.
  32. Zhao P, Maleki Z. Strongyloides stercoralis in bronchoalveolar lavage specimen processed as Prussian blue stain. Diagn Cytopathol 2013 Feb;41(2):141-3.
  33. Zheng G, Ettinger DS, Maleki Z. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors. Acta Cytol 2013 May-June;57(3):281-90.


  1. Dal Molin M, Matthaei H, Wu J, Blackford A, Debeljak M, Rezaee N, Wolfgang CL, Butturini G, Salvia R, Bassi C, Goggins MG, Kinzler KW, Vogelstein B, Eshleman JR, Hruban RH, Maitra A. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol 2013 Nov;20(12):3802-8.
  2. Harrington CT, Lin EI, Olson MT, Eshleman JR. Fundamentals of pyrosequencing. Arch Pathol Lab Med. 2013 Sep;137(9):1296-303.
  3. Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, TortoraG, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD. Exome sequencing reveals frequent inactivating mutations in BAP1, ARID1A, and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013 Dec;45(12):1470-3.
  4. Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, Karanam B, Liang H, Mullendore ME, Mo G, Hidalgo M, Jaffee E, Hruban RH, Jinnah HA, Roden RB, Jimeno A, Liu JO, Maitra A, Eshleman JR. Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res 2013 Mar 1;19(5):1139-46.
  5. Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto MI, Goggins M. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 2013 Jul;62(7):1024-33.
  6. Kanda M, Sadakari Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwara S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol 2013 Jun;11(6):719-30.e5.
  7. Le A, Dang CV. Studying Myc's role in metabolism regulation. Methods Mol Biol 2013;1012:213-9.
  8. Lewis GH, Wang H, Bellizzi AM, Klein AP, Askin FB, Schwartz LE, Schulick RD, Wolfgang CL, Cameron CL, O'Reilly EM, Yu KH, Hruban RH. Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2013 Apr;37(4):601-5.
  9. Li A, Yu J, Kim H, Wolfgang CL, Canto MI, Hruban RH, Goggins M. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res 2013 Jul 1;19(13):3600-10.
  10. Lin J, Bigge J, Ulbright TM, Montgomery E. Anastomosing hemangioma of the liver and gastrointestinal tract: an unusual variant histologically mimicking angiosarcoma. Am J Surg Pathol 2013 Nov;37(11):1761-5.
  11. Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis. J Surg Oncol 2013 Jan;107(1):8-14.
  12. Makohon-Moore A, Iacobuzio-Donahue CA. Considerations for sequencing analyses of pancreatic cancer progression and metastasis. Methods Mol Biol 2013;980:121-9.
  13. Matthaei H, Dal Molin M, Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Biol 2013;980:1-12.
  14. McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol 2013 Nov;37(11):1671-7.
  15. Robertson S, Hyder O, Dodson R, Nayar SK, Poling J, Beierl K, Eshleman JR, Lin MT, Pawlik TM, Anders RA. The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Hum Pathol 2013 Dec;44(12):2768-73.
  16. Salaria SN, Abu Alfa AK, Cruise MW, Wood LD, Montgomery EA. Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. Am J Surg Pathol 2013 Dec;37(12):1889-94.
  17. Sharma P, Montgomery E. Gastrointestinal dysplasia. Pathology JRCPA Apr 2013;45(3):273-85.
  18. Singhi AD, Norwood S, Liu TC, Sharma R, Wolfgang CL, Schulick RD, Zeh HJ, Hruban RH. Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium? Am J Surg Pathol 2013 Sep;37(0):1329-35.
  19. Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res 2013 Aug 1;19(15):4067-78.
  20. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA cancer J Clin 2013 Sep;63(5):318-48.
  21. Wood LD. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy. Mol Diagn Ther 2013 Oct;17(5):287-97.
  22. Wood LD, Heaphy CM, Daniel HJ, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove D, Boitnott J, Meeker AK, Torbenson M. Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphologic and molecular features. Mod Pathol 2013 Dec; 26(12):1586-93.
  23. Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett 2013 Jul 10;335(1):41-51.
  24. Yachida S, Iacobuzio-Donahue CA. Evolution and dynamics of pancreatic cancer progression. Oncogene. 2013 Nov 7;32(45):5253-60.
  25. Yegnasubramanian S, Maitra A. Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression. Cancer


  1. Al-Hussain TO, Cheng L, Zhang S, Epstein JI. Tubulocystic carcinoma of the kidney with poorly differentiated foci: A series of 3 cases with FISH analysis. Hum Pathol 2013 Jul;44:1406-11.
  2. Bagnasco S, Kraus E, Sis B. Diagnostic criteria for kidney transplant rejection: a call to action. Lancet 2013 Apr 27;381(9876):1458.
  3. Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin M, Epstein JI. Contemporary grading for prostate cancer: Implications for patient care. Eur Urol 2013 May;63:892-901.
  4. Chang A, Brimo F, Montgomery EA, Epstein JI. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol 2013 Aug;44(8):1563-8.
  5. Chaux A, Albadine R, Schultz L, Hicks J, Carducci MA, Argani P, Allaf M, Netto GJ. Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas. Hum Pathol 2013 Oct;44(10):2323-30.
  6. Chaux A, Comprat E, Varinot J, Hicks J, Lecksell K, Solus J, Netto GJ. High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral resection. Urology 2013 Jan;81(1):116-22.
  7. Chaux A, Han JS, Lee S, Gonzalez-Roibon N, Sharma R, Burnett AL, Cubilla AL, Netto GJ. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Hum Pathol. 2013 Dec;44(12):2760-7.
  8. Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, Burnett AL, Netto GJ. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol 2013 Dec;44(12):2690-5.
  9. Diolombi M, Ross HM, Mercalli F, Sharma R, Epstein JI. Nephrogenic adenoma: a report of 3 unusual cases infiltrating into perinephric adipose tissue. Am J Surg Pathol 2013 Apr;37(4):532-8.
  10. Ellis CL, Chang AG, Cimino-Mathews A, Argani P, Youssef RF, Kapur P, Montgomery EA, Epstein JI. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. Am J Surg Pathol 2013 Nov;37(11):1756-60.
  11. Ellis CL, Partin AW, Han M, Epstein JI. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: Correlation with findings at radical prostatectomy and prognosis. J Urol 2013 Dec;190(6):2068-73.
  12. Ellis CL, Walsh PC, Partin AW, Epstein JI. Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy. BJU Int 2013 Jun;111(8):E306-9.
  13. Faraj SF, Albadine R, Chaux A, Gonzalez-Roibon N, Hicks J, Humphreys E, Partin A, Netto GJ. Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate. Urology 2013 Nov;82(5):1083-9.
  14. Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, Netto G. Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol 2013 Jun;36(3):783-90.
  15. Giannico GA, Ross HM, Lotan T, Epstein JI. Aberrant expression of p63 in adenocarcinoma of the prostate: A radical prostatectomy study. Am J Surg Pathol 2013 Sep;37(9):1401-6.
  16. Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Hum Pathol 2013 Dec;44(12):2651-7.
  17. Gonzalez-Roibon ND, Chaux A, Al-Hussain T, Osunkoya AO, Bezerra SM, Hicks J, Epstein JI, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder. Hum Pathol 2013 Apr;44(4):612-22.
  18. Gonzalez-Roibon N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ. Comparison of biochemical recurrence free survival between periprostatic and pelvic lymph node metastases of prostate cancer. Int J Surg Pathol 2013 Aug;21(4):352-7.
  19. Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol 2013 Jul;44(7):1293-9.
  20. Green WM, Hicks JL, De Marzo AD, Illei PB, Epstein JI. Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate. Hum Pathol 2013 Sep;44(9):1895-901.
  21. Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discovery 2013 Oct;3(10):1130-41.
  22. Hempel HA, Burns KH, De Marzo AM, Sfanos KS. Infection of xenotransplanted human cell lines by murine retroviruses: a lesson brought back to light by XMRV. Front Oncol 2013 Jun 17;3:156.
  23. Kakiuchi Y, Choy B, Gordetsky J, Izumi K, Wu G, Rashid H, Joseph JV, Miyamoto H. Role of frozen section analysis of surgical margins during robot-assisted laparoscopic radical prostatectomy: a 2,608-case experience. Hum Pathol 2013 Aug;44(8):1556-62.
  24. Kao S, Epstein JI. Tubular adenoma of the urinary tract: a newly described entity. Hum Pathol 2013 Sep;44(9):1890-4.
  25. Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua T, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res 2013 Dec 15;73(24):7162-7.
  26. Kryvenko ON, Epstein JI. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients. J Urol 2013 Jun;189(6):2083-6.
  27. Kryvenko ON, Epstein JI. Testicular hemangioma: a series of 8 cases. Am J Surg Pathol 2013 Jun;37(6):860-6.
  28. Kryvenko ON, Roquero L, Gupta NS, Lee MW, Epstein JI. Low-grade clear cell renal cell carcinoma mimicking hemangioma of the kidney: a series of 4 cases. Arch Pathol Lab Med 2013 Feb;137(2):251-4.
  29. Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Hum Pathol 2013 Mar;44(3):427-31.
  30. Lee S, Han JS, Ross HM, Epstein JI. Massive localized lymphedema of the male external genitalia: A clinicopathologic study of 7 cases. Hum Pathol 2013 Feb;44(2):277-81.
  31. Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H. Androgen activates“-catenin signaling in bladder cancer cells. Endocr Relat Cancer 2013 June 1;20(3):293-304.
  32. Lotan TL, Gumuskaya B, Rahimi H, Hicks JL, Iwata T, Robinson BD, Epstein JI, De Marzo AM. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod Pathol 2013 Apr;26(4):587-603.
  33. Mak TN, Yu SH, De Marzo AM, Brüggemann H, Sfanos KS. Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. Prostate 2013 May;73(7):770-7.
  34. Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma. Hum Pathol 2013 Dec;44(12):2668-76.
  35. Neto GJ. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"? Adv Anat Pathol 2013 May;20(3):175-203.
  36. Nie X, Arend LJ. Pkd1 is required for male reproductive tract development. Mech Dev 2013 Nov-Dec;130(11-12):567-76.
  37. Pan CC, Epstein JI. Common chromosomal aberrations detected by array comparative genomic hybridization in specialized stromal tumors of the prostate. Mod Pathol 2013 Nov:1536-43.
  38. Pierorazio PM, Walsh PW, Partin AW, Epstein JI. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 2013 May;111:753-60.
  39. Sfanos KS, Isaacs WB, DeMarzo AM. Infections and inflammation in prostate cancer. Am J Clin and Exp Urol Dec 2013;1(1):3-11.
  40. Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Brüggemann H, Nelson WG, De Marzo AM, Yegnasubramanian S, Sfanos KS. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 2013 Jun;73(9):1007-15.
  41. So JS, Epstein JI. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol 2013 Oct;26(10):1365-70.
  42. Tavora F, Kryvenko ON, Epstein JI. Mesenchymal tumours of the bladder and prostate: an update. Pathology 2013 Feb;45(2):104-15.
  43. Venigalla S, Wu G, Miyamoto H. The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: A clinicopathologic study of 433 cases. Clin Genitourin Cancer 2013 Dec;11(4):527-36.
  44. Zhang M, Amberson JB, Epstein JI. Two sequential diagnoses of atypical foci suspicious for carcinoma on prostate biopsy: a follow-up study of 179 cases. Urology 2013 Oct;82(4):861-4.
  45. Zhang M, Kao S, Ulbright TM, Epstein JI. Testicular fibrothecoma: a morphological and immunohistochemical study of 16 cases. Am J Surg Pathol 2013 Aug;37(8):1208-14.


  1. Anchoori RK, Karanam B, Peng S, Wang JW, Jiang R, Tanno T, Orlowski RZ, Matsui W, Zhao M, Rudek MA, Hung CF, Chen X, Walters KJ, Roden RB. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell 2013 Dec 9;24(6):791-805.
  2. Bagby C, Ronnett BM, Yemelyanova A, Maleki Z, Kuhn E, Vang R. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Int J Gynecol Pathol 2013 Sep;32(5):433-43.
  3. Chang CL, Hsu YT, Wu CC, Lai YZ, Wang C, Yang YC, Wu TC, Hung CF. Dose-dense chemotherapy improves mechanisms of antitumor immune response. Cancer Res 2013 Jan 1;73(1):119-27.
  4. Guan B, Magomi T, Wang TL, Shih IeM. Establishing isogenic inducible cell lines using founder reporter lines and recombinase-mediated cassette exchange. Biotechniques 2013 Nov;55(5):233-42.
  5. Kang TH, Knoff J, Yang B, Tsai YC, He L, Hung CF, Wu TC. Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide. Cell Biosci 2013 Dec 20;3(1):48.
  6. Kang TH, Mao CP, La V, Chen A, Hung CF, Wu TC. Innovative DNA vaccine to break immune tolerance against tumor self-antigen. Hum Gene Ther 2013 Feb;24(2):181-8.
  7. Kang TH, Mao CP, Lee SY, Chen A, Lee JH, Kim TW, Alvarez RD, Roden RB, Pardoll D, Hung CF, Wu TC. Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Res 2013 Apr 15;73(8):2493-504.
  8. Kuhn E, Ayhan A, Shih IeM, Seidman JD, Kurman RJ. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 2013 Dec;49(18):3839-49.
  9. Kurman RJ, Visvanathan K, Shih IeM. Bokhman's dualistic model of endometrial carcinoma. Revisited. Gynecol Oncol 2013 May;129(2):271-2.
  10. Lee SY1, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC. J Mol Med (Berl). 2013 Oct;91(10):1221-31.
  11. Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, Wu TC. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Cancer Immunol Immunother. 2013 Jul;62(7):1175-85.
  12. Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including some with a molar component: morphology, p57 immunohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol 2013 Mar;32(2):199-214.
  13. Maeda D, Shih IeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013 Jan;20(1):45-52.
  14. Maniar KP, Ronnett BM, Vang R, Yemelyanova A. Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients. Am J Surg Pathol. 2013 Jan; 37(1):53-60.
  15. Mao TL, Ardighieri L, Ayhan A, Kuo KT, Wu CH, Wang TL, Shih IeM. Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. Am J Surg Pathol. 2013 Sep;37(9):1342-8.
  16. Mao TL, Shih IM. The roles of ARID1A in gynecologic cancer. J Gynecol Oncol. 2013 Oct;24(4):376-81.
  17. Sheu JJ, Choi JH, Guan B, Tsai FJ, Hua CH, Lai MT, Wang TL, Shih IeM. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development. J Pathol 2013 Mar;229(4):559-68.
  18. Soong RS, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53. PLoS One. 2013 Feb;8(2):e56912.
  19. Vang R, Shih IeM, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 2013 Jan;62(1):44-58.
  20. Yap KL, Shah PS, Bolon B, Wu RC, Gao M, Wang F, Faiola F, Huso D, Wang TL, Wang JL, Shih IM. Loss of NAC1 expression is associated with defective cell fate specification and bony patterning in the murine vertebral axis. PLoS One 2013 Jul;8:e69099.
  21. Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Mod Pathol 2013 Feb;26(2):268-74.


  1. Babatz TD, Burns KH. Functional impact of the human mobilome. Curr Opin Genet Dev 2013 Jun;23(3):264-70.
  2. Gnanakkan VP, Jaffe AE, Dai L, Fu J, Wheelan SJ, Levitsky HI, Boeke JD, Burns KH. TE-array--a high throughput tool to study transposon transcription. BMC Genomics 2013 Dec 10;14:869.
  3. Halper-Stromberg E, Steranka J, Giraldo-Castillo N, Fuller T, Desiderio S, Burns KH. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies. BMC Genomics 2013 Aug 19;14:565.
  4. Rodić N, Burns KH. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 2013 Mar;9(3):e1003402.
  5. Rodić N, Zampella JG, Cornish TC, Wheelan SJ, Burns KH. Translocation junctions in TCF3-PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements. Mob DNA 2013 Oct 17;4(1):22.
  6. Samols MA, Smith NE, Gerber JM, Vuica-Ross M, Gocke CD, Burns KH, Borowitz MJ, Cornish TC, Duffield AS. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas. Am J Clin Pathol 2013 Oct;140(4):579-87.
  7. Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance. Am J Clin Pathol. 2013 Apr;139(4):450-6.
  8. Tilson MP, Jones RJ, Sexauer A, Griffin CA, Morsberger LA, Batista DA, Small D, Burns KH, Gocke CD, Vuica-Ross M, Borowitz MJ, Duffield AS. Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities. Biol Blood Marrow Transplant. 2013 Aug;19(8):1254-9.


  1. Amukele TK, Soko D, Katundu P, Kamanga M, Sun J, Kumwenda NI, Taha TE. Vitamin D levels in Malawian infants from birth to 24 months. Arch Dis Child 2013 Mar;98(3):180-3.
  2. Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Fairweather D, Bedja D, Stickel NR, Fontes JA, Cardamone AB, Zheng D, Gabrielson KL, Rose NR, Cihakova D. Fatal Eosinophilic Myocarditis Develops in the Absence of IFN-γ‚ and IL-17A. J Immunol 2013 Oct 15;191(8):4038-47.
  3. Barin JG, Cihakova D. Control of inflammatory heart disease by CD4(+) T cells. Ann N Y Acad Sci 2013 May;1285(1):80-96.
  4. Caturegli P Dr, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto Thyroiditis: celebrating the centennial through the lens of The Johns Hopkins Hospital Surgical Pathology records. Thyroid 2013 Feb;23(2):142-50.
  5. Elbireer AM, Jackson JB, Sendargire H, Opio A, Bagenda D, Amukele TK. The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda. PLoS ONE 2013 May;8(5):e6466.
  6. Hoffman WH, Passmore GG, Hannon DW, Talor MV, Fox P, Brailer C, Haislip D, Keel C, Harris G, Rose NR, Fiordalisi I, Cihakova D. Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis. PLoS One. 2013 Aug 27;8(8):e71905.
  7. Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab 2013 Oct;98(10):3920-5.
  8. Kim A, Ishizuka I, Hartman I, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC class II peptide loading and editing in vitro. Methods Mol Biol 2013;960:447-59.
  9. Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLoS One 2013 Aug 8;8(8):e71228.
  10. Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and its role in MHC class II antigen presentation. Front Immunol 2013 Aug;4(article260):1-5.
  11. Ramirez L, Hamad AR. Status of autoimmune diabetes 20-year after generation of BDC2.5-TCR transgenic non-obese diabetic mouse. World J Diabetes 2013 Aug 15;4(4):88-91. 12. Zheng G, Chaux A, Sharma R, Netto G, Caturegli P. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma. Exp Mol Pathol 2013 Feb;94(1):29-32.


  1. Lai H, Fishman EK, Gerstenblith G, Brinker B, Hong T, Chen S, Li J, Tong W, Detrick B, Lai S. Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection. Vasc Health Risk Manag 2013;9:493-500.


  1. Bell WR, Dalton JB, McCall CM, Karram S, Pearce DT, Memon W, Lee R, Carroll KC, Lyons JL, Gireesh ED, Trivedi JB, Cettomai D, Smith BR, Chang T, Tochen L, Ratchford JN, Harrison DM, Ostrow LW, Stevens RD, Chen L, Zhang SX. Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findings. Mod Pathol 2013 Feb;26(2):166-70.
  2. Burnham CA, Carroll KC. Diagnosis of clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013 Jul;26(3):604-30.
  3. Carroll KC, Buchan BW, Tan S, Stamper PD, Riebe KM, Pancholi P, Kelly C, Rao A, Fader R, Cavagnolo R, Wilson W, Goering RV, Trevino EA, Weissfeld AS, Ledeboer NA. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid test. J Clin Microbiol 2013 Dec;51(12):4120-5.
  4. Choi KS, Dumler JS. Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling. Microbiol Immunol 2013 Mar;57(3):207-12.
  5. Eisinger SW, Schwartz M, Dam L, Riedel S. Evaluation of the BD Vacutainer Plus Urine C&S Preservative Tubes Compared With Nonpreservative Urine Samples Stored at 4°C and Room Temperature. Am J Clin Pathol 2013 Sep;140(3):306-13.
  6. Farley JE, Ross T, Krall J, Hayat M, Caston-Gaa A, Perl T, Carroll KC. Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus nasal and axillary colonization among psychiatric patients on admission to an academic medical center. Am J Infect Control 2013 Mar;41(3):199-203.
  7. Grab DJ, Nenortas E, Bakshi R, Nikolskaia OV, Friedman JE, Shapiro TA. Membrane active chelators as novel anti-African trypanosome and anti-malarial drugs. Parasitol Int 2013 Oct;62(5):461-3.
  8. Hirsch HH, Lautenschlager I, Pinsky BA, Cardeñoso L, Aslam S, Cobb B, Vilchez RA, Valsamakis A. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013 Feb;56(3):367-73.
  9. LeBlanc RE, Meriden Z, Sutton DA, Thompson EH, Neofytos D, Zhang SX. Cunninghamella echinulata causing fatally invasive fungal sinusitis. Diagn Microbiol Infect Dis 2013 Aug;76(4):506-9.
  10. Liu CM, Soldanova K, Nordstrom L, Dwan MG, Moss OL, Contente-Cuomo TL, Keim P, Price LB, Lane AP. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol 2013 Oct;3(10):775-81.
  11. Lyons JL, Roos KL, Marr KA, Neumann H, Trivedi JB, Kimbrough DJ, Steiner L, Thakur KT, Harrison DM, Zhang SX. Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid to diagnose iatrogenic fungal meningitis. J Clin Microbiol 2013 April;51(4):1285-7.
  12. Reller ME, Akoroda U, Nagahawatte A, Devasiri V, Kodikaarachchi W, Strouse JJ, Chua R, Hou Y, Chow A, Sessions OM, Ostbye T, Gubler DJ, Woods CW, Bodinayake C. Chikungunya as a cause of acute febrile illness in southern Sri Lanka. PLoS One 2013 Dec 2;8(12):e8225.
  13. Reller ME, Chen WH, Dalton J, Lichay MA, Dumler JS. Multiplex 5' nuclease quantitative real-time PCR for clinical diagnosis of malaria and species-level identification and epidemiologic evaluation of malaria-causing parasites, including Plasmodium knowlesi. J Clin Microbiol 2013 Sep;51(9):2931-8.
  14. Riedel S, Carroll KC. Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med 2013 Sep;33(3):413-37.
  15. Tamma PD, Girdwood SC, Gopaul R, Tekle T, Roberts AA, Harris AD, Cosgrove SE, Carroll KC. The use of cefepime for treating AmpC B-lactamase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57:781-8.
  16. Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis 2013 Jan;75(1):9-15.
  17. Zhang SX. Enhancing molecular approaches for diagnosis of fungal infections. Future Microbiol 2013 Dec;8:1599-611.


  1. Beierl K, Tseng LH, Beierl R, Haley L, Gocke CD, Eshleman JR, Lin MT. Detection of minor clones with internal tandem duplication mutations of FLT3 gene in acute myeloid leukemia using delta-PCR. Diagn Mol Pathol 2013 Mar;22(1):1-9.
  2. Henderson LB, Corson VL, Saul DO, Anderson C, Millard S, Batista DA, Blakemore KJ, Descipio C. First trimester diagnosis of holoprosencephaly secondary to a ring chromosome 7. Case Rep Genet 2013 Feb;2013:578202.
  3. Lee RW, Bodurtha J, Cohen J, Fatemi A, Batista D. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013 Apr;48(4):317-20.
  4. Lin MT, Tseng LH, Beierl K, Thiess M, Chase N, Stafford A, Levis M, Eshleman JR, Gocke CD. Tandem duplication PCR: an ultra-sensitive assay for the detection of internal tandem duplications of the FLT3 gene. Diagn Mol Pathol 2013 Sep;22(3):149-55.
  5. Ning Y, Foss A, Kimball AS, Neill N, Matz T, Schultz R. Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia. Mol Cytogenet 2013 Aug 28;6(1):34.


  1. Bell RW, Jusue-Torres I, Quinones-Hinojosa A, Rodriguez F. Inflammatory myofibroblastic tumor involving the central nervous system. Path Case Rev 2013 Nov-Dec;18(6):257-61.
  2. Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo notch blockade. Clin Cancer Res 2013 Jun 15;19(12):3224-33.
  3. Heaphy CM, Schreck KC, Raabe E, Mao XG, An P, Chu Q, Poh W, Jiao Y, Rodriguez FJ, Odia Y, Meeker AK, Eberhart CG. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol 2013 Oct;124(4):607-8.
  4. Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro Oncol 2013 Jan;15(1):69-82.
  5. Hütt-Cabezas M, Karajannis MA, Zagzag D, Shah S, Horkayne-Szakaly I, Rushing EJ, Cameron JD, Jain D, Eberhart CG, Raabe EH, Rodriguez FJ. Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro Oncol 2013 Dec;15(12):1604-14.
  6. Laclair KD, Manaye KF, Lee DL, Allard JS, Savonenko AV, Troncoso JC, Wong PC. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener 2013 Jun 13;8:18.
  7. Martin LJ, Katzenelson A, Koehler RC, Chang Q. The olfactory bulb in newborn piglet is a reservoir of neural stem and progenitor cells. PLoS One 2013 Nov 21;8(11):e81105.
  8. Martin LJ, Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics 2013 Oct;10(4):722-33
  9. Magalhães J, Rostad S, Foltz G, Pytel P, Rodriguez FJ. Cellular pleomorphism in papillary tumors of the pineal region. Brain Tumor Pathol 2013 Apr;30(2):93-8.
  10. Melnikova T, Fromholt S, Kim HS, Lee D, Xu G, Price A, Moore BD, Golde TE, Felsenstein KM, Savonenko AV, Borchelt DR. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis. J Neurosci 2013 Feb;33(9):3765-79.
  11. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol 2013 May;23(3):237-43.
  12. Odia Y, Orr BA, Robert Bell W, Eberhart CG, Rodriguez FJ. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. J Neurooncol 2013 Nov;115(2):249-59.
  13. Rodriguez FJ, Lim KS, Bowers D, Eberhart CG. Pathological and molecular advances in pediatric low-grade astrocytoma. Annu Rev Pathol 2013 Jan 24;8:361-79.
  14. Wong M, Gertz B, Chestnut BA, Martin LJ. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front Cell Neurosci 2013 Dec 25;7:279.
  15. Woodworth GF, Garzon-Muvdi T, Ye X, Blakeley JO, Weingart JD, Burger PC. Histopathological correlates with survival in reoperated glioblastomas. J Neurooncol 2013 Jul;113(3):485-93.


  1. Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG. A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci 2013 Jan 9;54(1):295-306.
  2. Rajaii F, Ghafourian A, Eberhart CG. Intratarsal keratinous cyst - an emerging entity. Case Rep Ophthalmol. 2013 Oct 5;4(3):160-4.


  1. Belchis DA, Shekitka K, Gocke CD. Multi-institutional retrospective cohort study of spontaneous pneumothorax. Pathol Res Pract 2013 Aug;209(8):486-9.
  2. Bishop JA. Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol 2013 Mar;7(1):35-9.
  3. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, Westra WH. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013 Feb;37(2):185-92.
  4. Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Pai SI, Westra WH. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. 2013 Jun;37(6):836-44.
  5. Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol 2013 Oct;44(10):1982-8.
  6. Bishop JA, Yonescu R, Batista D, Eisele DW, Westra WH. Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas. Am J Surg Pathol 2013 Jul;37(7):1053-7.
  7. Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway. Hum Pathol 2013 Nov;44(11):2494-500.
  8. Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol 2013 Jun;44(6):959-65.
  9. Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Hum Pathol 2013 Jul;44(7):1341-9.
  10. Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol 2013 Aug;37(8):1150-63.
  11. McCarthy EF. Fibro-osseous lesions of the maxillofacial bones. Head Neck Pathol 2013 Mar;7(1):5-10.
  12. Rooper L, Gocke CD, Belchis, DA. Pleural fluid cytology of the polymorphous variant of EBV-positive diffuse large B-cell Lymphoma: first report and distinction from a reactive process. Case Rep Pathol 2013;2013:459279. Ruzevick J, Olivi A, Westra WH. Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol 2013 May;112(3):449-54.
  13. Schwartz LE, Begum S, Westra WH, Bishop JA. GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol 2013 Dec;7(4):311-5.
  14. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013 Oct;37(10):1469-89.
  15. Vandenbussche CJ, Khouri N, Sbaity E, Tsangaris TN, Vang R, Tatsas A, Cimino-Mathews A, Argani P. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol 2013 Jun;37(6):913-23.
  16. Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani P. A broad survey of cathepsin k immunoreactivity in human neoplasms. Am J Clin Pathol 2013 Feb;139(2):151-9.


  1. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. HIV incidence estimation using multiple biomarkers. Am J Epidemiol 2013 Feb;177:264-72.
  2. Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH. Cross-sectional HIV incidence estimation in HIV prevention research. J AIDS 2013 Jul;63:S233-S237.
  3. Cousins MM, Donnell D, Eshleman SH. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. J Mol Diagn 2013 Jan;15(1):130-7.
  4. Davis MA, Gray RH, Grabowski MK, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Watya S, Wawer MJ, Quinn TC, Tobian AA. Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda. Int J Cancer 2013 Sep 1;133(5):1247-52.
  5. Elbireer A, Le Chasseur J, Jackson B. Improving laboratory data entry quality using Six Sigma. Int J Health Care Qual Assurance 2013 July;26(6):496-509.
  6. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J Jr, Vallari AS, Justman J, Hodder S. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 2013 Jan;207(2):223-31.
  7. Fogel J, Mwatha A, Richardson P, Brown E, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. Pediatr Infect Dis J 2013 Apr;32(4):e164-e169.
  8. Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, Bumpus NN, Hendrix CW, Cohen MS, Eshleman SH. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis 2013 Nov;208(10):1624-8.
  9. Jackson JB, Tao X, Sneed L, Humphrey-Carothers F, Bernacki E. Cost of annual tuberculosis screening of healthcare workers with negative tuberculin skin test results. Infect Control Hosp Epidemiol 2013 Jun;34(6):642-3.
  10. James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH. Antibody maturation and viral diversification in HIV-infected women. PLoS One 2013 Feb;8(2): e57350.
  11. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Male circumcision cost-effective articles ignore methodological problems and ethical concerns - reply. JAMA Pediatr 2013;167:198-200.
  12. Kacker S, Frick KD, Tobian AA. Constructing a model: economic evaluations in transfusion medicine, PartÔÇë3. Transfusion 2013 Sep;53(9):1885-7.
  13. Kacker S, Frick KD, Tobian AAR. Data and interpretation: economic evaluations in transfusion medicine part 4. Transfusion 2013 Oct;53:2130-3.
  14. Kacker S, Frick KD, Tobian AAR. Establishing a framework: economic evaluations in transfusion medicine part 2. Transfusion 2013 Aug;53(8):1634-6.
  15. Kacker S, Frick KD, Tobian AA. The costs of transfusion: economic evaluations in transfusion medicine, PartÔÇë1. Transfusion 2013 Jul;53(7):1383-5.
  16. Kacker S, Frick KD, Quinn TC, Gray RH, Tobian AAR. Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community. Sex Transm Dis 2013 Jul;40(7):559-68.
  17. Kacker S, Tobian AAR. Male circumcision: integrating tradition and medical evidence. Isr Med Assoc J 2013;15:37-8.
  18. Kacker S, Ness PM, Savage WJ, Frick KD, McCullough J, King KE, Tobian AAR. Costs and effectiveness of platelet additive solution to prevent allergic transfusion reactions. Transfusion 2013 Nov; 53:2609-18.
  19. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. HIV Incidence determination in the United States: A multiassay approach. J Infect Dis 2013 Jan;207(2):232-9.
  20. Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison C, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Abdool Karim, Q, Naranbhai V, Lingpappa J, Sweat MD, Coates T, Eshleman SH. Development of methods for cross-sectional incidence HIV estimation in a large community-randomized trial. PLoS One 2013 Nov;8(11):e78818.
  21. Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Vallari A, Hackett J, Jr., Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, Mbwambo J, Chariyalertsak S, Chingono A, Celantano D, Morin SF, Sweat M, Coates T, Eshleman SH. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH Project Accept (HIV Prevention Trials Network 043). PLoS ONE 2013 July11;8(7):e68349
  22. Liu CM, Hungate BA, Tobian AAR, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, Contente-Cuomo TL, Wawer MJ, Keim P, Gray RH, Price LB. Male circumcision significantly reduces prevalence and load of anaerobic bacteria. mBio 2013 Apr;4(2):e00076-1.
  23. Morris BJ, Tobian AAR. Legal threat to infant male circumcision. JAMA Pediatr 2013 Oct;167:890-1.
  24. Redd AD, Quinn TC, Tobian AAR. Frequency and implications of HIV superinfection. Lancet Infecti Dis 2013 Jul;13(7):622-8.
  25. Savage WJ, Tobian AA, Savage JH, Wood RA, Schroeder JT, Ness PM. Scratching the surface of allergic transfusion reactions. Transfusion 2013 Jun;53(6):1361-71.
  26. Tobian AAR, Grabowski MK, Kigozi G, Gravitt PE, Eaton K, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2013 Mar;89(2):122-7.
  27. Tobian AA, Grabowski MK, Kigozi G, Redd AD, Eaton KP, Serwadda D, Cornish TC, Nalugoda F, Watya S, Buwembo D, Nkale J, Wawer MJ, Quinn TC, Gray RH. Human papillomavirus clearance in men is associated with HIV acquisition and increased foreskin dendritic cell density in Rakai, Uganda. J Infect Dis 2013 Jun;207(11):1713-22.
  28. Tobian AA, Grabowski MK, Serwadda D, Newell K, Ssebbowa P, Franco V, Nalugoda F, Wawer MJ, Gray RH, Quinn TC, Reynolds SJ; Rakai Health Sciences Program. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy. J Infect Dis 2013 Sep 1;208(5):839-46.
  29. Tobian A, Kacker S. Some comments on male circumcision. Isr Med Assoc J 2013 Jul;15(7):393.
  30. Tobian AAR, Kigozi G, Wawer MJ, Serwadda D, Quinn TC, Gray RH. Herpes simplex virus type-2 (HSV-2) assay specificity and male circumcision to reduce HSV-2 acquisition. AIDS 2013;27:147-9.
  31. Treml A, King KE. Red blood cell alloimmunization: lessons from sickle cell disease. Transfusion. 2013 Apr;53(4):692-5.
  32. Wang J, Liu J, Yao F, Wen G, Li J, Huang Y, L Y, Wen X, Wright D, Yu Q, Guo N, Ness P, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) and International Component. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors. Transfusion 2013 Jun;53(6):1240-9.
  33. Weiskopf RB, Ness PM. Transfusion for remote damage control resuscitation. Transfusion. 2013 Jan;53(1):8-12.